Bayer wins in Alesi v Monsanto jury

The Missouri state court jury, United States, ruled in favor of Bayer in the Alesi v. Monsanto, which dealt with compensation for cancer allegedly resulting from glyphosate. The decision took place yesterday, September 01, 2022; on the same day that the parties' final arguments were delivered. It was the first case trial involving the product in the Saint Louis area.

The three plaintiffs alleged exposure to glyphosate in the 1960s and 1970s during home spraying (in their backyards). His thesis was based on Monsanto's alleged knowledge of the product's carcinogenic properties and concealment of information from the public.

The defense maintained that studies associating cancer with glyphosate exposure contain flaws. And many other studies point to the safety of the product.

Regarding the case, Bayer commented as follows:

"The jury's verdict in favor of the company brings this trial to a successful conclusion and is consistent with the evidence in this multi-party case that Roundup was not responsible for the injuries alleged by the plaintiffs.

The jury's findings are consistent with the assessments of expert regulators around the world, as well as the overwhelming evidence from four decades of scientific studies concluding that Roundup can be used safely and is not carcinogenic.

The firm won the four previous Roundup trials, including the Clark, Stephens, Shelton and Johnson cases, and with the victory in Alesi, it has prevailed in five consecutive trials.

While we have great sympathy for the plaintiffs in this case, the jury weighed the evidence on both sides in this case and concluded that Roundup is not responsible for your injuries.

We continue to support the safety of Roundup and will confidently defend the safety of our product as well as our good faith actions in any future litigation."

The case in question is Carl Alesi, et al. v. Monsanto Company; number19SL-CC03617, in St. Louis County Circuit Court, Missouri.